Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Neuren Pharmaceuticals.
RELATED STOCKHEAD STORIES
Experts
Money Talks: Could one of these stock picks be the next ‘billion-dollar biotech’?
Health & Biotech
Tim Boreham (and Acadia) go through Neuren’s undies drawer
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
Health & Biotech
Neuren shareholders throw their toys after licensing deal; shares plummet 45pc
Health & Biotech